Ankylosing spondylitis generally does not affect the life expectancy of patients, but when there is involvement of various systems of the body, especially when there are serious complications in important organs, their life expectancy may be affected.
Ankylosing spondylitis is an autoimmune disease that mainly affects the spine and the large joints of the limbs, and patients may suffer from morning stiffness, low back pain, limited joint movement, etc. As the disease continues to progress, joint deformities and disabilities may occur, which seriously affects the quality of life of patients. However, the prognosis can be effectively improved through active treatment, which has little effect on life expectancy.
If there is no timely and active treatment, with the progress of the disease, some patients may develop iritis, aortitis, interstitial pneumonitis and other systemic involvement, which may have a certain impact on the patient’s life expectancy.
It is recommended that patients with ankylosing spondylitis go to the rheumatology and immunology department of a regular hospital for consultation, standardized diagnosis and treatment under the guidance of a doctor, and regular follow-up.